Treace Medical Concepts (TMCI) Operating Leases (2022 - 2026)

Treace Medical Concepts has reported Operating Leases for 5 years, with the latest figure at $13.6 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 2.57% year-over-year to $13.6 million; the trailing twelve-month figure through Mar 2026 stood at $13.6 million (down 2.57% YoY), and the FY2025 full-year result was $14.0 million, down 12.25% from the prior year.
• Operating Leases for Q1 2026 stood at $13.6 million, down from $14.0 million in the prior quarter.
• The five-year high for Operating Leases was $19.0 million in Q3 2022, with the low at $12.9 million in Q3 2025.
• Historically, Operating Leases has averaged $15.6 million across 5 years, with a median of $15.9 million in 2023.
• Annual changes were most pronounced in 2024 — Operating Leases advanced 4.65% — and 2025, when it retreated 21.57%.
• Treace Medical Concepts' Operating Leases stood at $15.5 million in 2022, then gained by 2.27% to $15.9 million in 2023, then climbed by 0.27% to $15.9 million in 2024, then dropped by 12.25% to $14.0 million in 2025, then dropped by 3.08% to $13.6 million in 2026.
• The last three Operating Leases figures came in at $13.6 million (Q1 2026), $14.0 million (Q4 2025), and $12.9 million (Q3 2025), per Business Quant data.